Enzalutamide--a major advance in the treatment of metastatic prostate cancer
- PMID: 23013078
- DOI: 10.1056/NEJMe1209041
Enzalutamide--a major advance in the treatment of metastatic prostate cancer
Comment on
-
Increased survival with enzalutamide in prostate cancer after chemotherapy.N Engl J Med. 2012 Sep 27;367(13):1187-97. doi: 10.1056/NEJMoa1207506. Epub 2012 Aug 15. N Engl J Med. 2012. PMID: 22894553 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources